Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
Early additional donor natural killer cell infusion after HLA-haploidentical hematopoietic cell transplantation is not associated with an enhanced antileukemia effect
•
Early donor natural killer cell infusion after HLA-haploidentical hematopoietic cell transplantation is associated with significant toxicities related to cytokine release
•
Higher NKp30 expression on donor natural killer cells is an independent predictor for higher complete remission and less leukemia progression after HLA-haploidentical hematopoietic cell transplantation and donor natural killer cell infusion
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.